Martin P Bogsrud

Martin P Bogsrud

UNVERIFIED PROFILE

Are you Martin P Bogsrud?   Register this Author

Register author
Martin P Bogsrud

Martin P Bogsrud

Publications by authors named "Martin P Bogsrud"

Are you Martin P Bogsrud?   Register this Author

26Publications

460Reads

16Profile Views

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia.

Adv Ther 2019 Jul 17;36(7):1786-1811. Epub 2019 May 17.

Lipid Clinic, Heart Institute (InCor), University of Sao Paulo and Hospital Israelita Albert Einstein, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12325-019-00985-8
Publisher Site
http://dx.doi.org/10.1007/s12325-019-00985-8DOI Listing
July 2019

LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.

J Clin Lipidol 2019 Mar - Apr;13(2):279-286. Epub 2019 Jan 30.

Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2019.01.010DOI Listing
January 2019

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

Atherosclerosis 2018 10;277:234-255

Imperial Centre for Cardiovascular Disease Prevention (ICCP), Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2018.08.051DOI Listing
October 2018

Some children with a familial hypercholesterolemia mutation may exhibit persistent low LDL levels.

J Clin Lipidol 2018 Sep - Oct;12(5):1327-1328. Epub 2018 Jun 28.

Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital, Oslo, Norway; Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.06.012DOI Listing
June 2018

Delayed postprandial TAG peak after intake of SFA compared with PUFA in subjects with and without familial hypercholesterolaemia: a randomised controlled trial.

Br J Nutr 2018 05;119(10):1142-1150

1Norwegian National Advisory Unit on Familial Hypercholesterolemia,Department of Endocrinology,Morbid Obesity and Preventive Medicine,Oslo University Hospital,Forskningsveien 2B,0373 Oslo,Norway.

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S000711451
Publisher Site
http://dx.doi.org/10.1017/S0007114518000673DOI Listing
May 2018

Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH.

J Clin Lipidol 2018 May - Jun;12(3):748-755.e2. Epub 2018 Mar 9.

Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2018.02.021DOI Listing
March 2018

Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway.

J Clin Lipidol 2018 Mar - Apr;12(2):375-382. Epub 2017 Dec 6.

Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacl.2017.11.009DOI Listing
December 2017

Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study.

Atherosclerosis 2017 Nov 21;266:48-57. Epub 2017 Sep 21.

Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, P.O box 1046 Blindern, 0317 Oslo, Oslo, Norway; Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University, Hospital Rikshospitalet, P.O box 4950 Nydalen, 0424 Oslo, Oslo, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2017.09.021DOI Listing
November 2017

Increased risk of heart failure and atrial fibrillation in heterozygous familial hypercholesterolemia.

Atherosclerosis 2017 Nov 28;266:69-73. Epub 2017 Sep 28.

The Lipid Clinic, Oslo University Hospital Rikshospitalet, Oslo, Norway; Department of Nutrition, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2017.09.027DOI Listing
November 2017

Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.

Curr Opin Lipidol 2017 10;28(5):445-447

aNorwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Endocrinology, Morbid Obesity, and Preventive Medicine bDepartment of Nutrition, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000449DOI Listing
October 2017

Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children.

Data Brief 2017 Feb 29;10:587-592. Epub 2016 Dec 29.

Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, P.O box 1046 Blindern, Oslo 0317, Norway; Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital Rikshospitalet, P.O box 4950 Nydalen, Oslo 0424, Norway.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523409163080
Publisher Site
http://dx.doi.org/10.1016/j.dib.2016.12.042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219596PMC
February 2017

Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia.

Atherosclerosis 2017 01 1;256:67-74. Epub 2016 Dec 1.

Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, P.O box 1046, Blindern, 0317 Oslo, Norway; Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital Rikshospitalet, P.O box 4950, Nydalen, 0424 Oslo, Norway. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00219150163151
Publisher Site
http://dx.doi.org/10.1016/j.atherosclerosis.2016.11.031DOI Listing
January 2017

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

Atheroscler Suppl 2016 Dec 7;22:1-32. Epub 2016 Dec 7.

Imperial Centre for Cardiovascular Disease Prevention (ICCP), School of Public Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosissup.2016.10.001DOI Listing
December 2016

Does intrauterine exposure to hypercholesterolemia adversely affect familial hypercholesterolemia phenotype?

Curr Opin Lipidol 2016 08;27(4):382-7

aDepartment of Endocrinology, Morbid Obesity, and Preventive Medicine, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital bDepartment of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0000000000000299DOI Listing
August 2016

UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone.

Mol Diagn Ther 2013 Aug;17(4):233-7

Department of Medical Biochemistry, Oslo University Hospital, University of Oslo, Nydalen, P.O. Box 4956, 0424, Oslo, Norway.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s40291-013-0031
Web Search
http://link.springer.com/10.1007/s40291-013-0031-x
Publisher Site
http://dx.doi.org/10.1007/s40291-013-0031-xDOI Listing
August 2013

Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.

Cytokine 2013 Jan 4;61(1):194-8. Epub 2012 Nov 4.

Lipid Clinic, Oslo University Hospital Rikshospitalet, and Department of Nutrition, Institute for Basic Medical Sciences, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10434666120070
Publisher Site
http://dx.doi.org/10.1016/j.cyto.2012.09.016DOI Listing
January 2013

Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.

Mol Diagn Ther 2011 Aug;15(4):221-7

School of Pharmacy, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF03256413DOI Listing
August 2011

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.

Clin Pharmacol Ther 2006 Jun;79(6):532-9

Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, and Lipid Clinic, Rikshospitalet, Norway.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1016/j.clpt.2006.02.014
Publisher Site
http://dx.doi.org/10.1016/j.clpt.2006.02.014DOI Listing
June 2006